Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genexol-PM plus standard postoperative chemoradiotherapy for adjuvant treatment of glioblastoma
ChiCTR2400091868Phase 4Not yet recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Nov 2024
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of paclitaxel polymeric micelle in glioblastoma (GBM), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: progression-free survival. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
paclitaxel polymeric micelle
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on ChiCTR2400091868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091868.